31 citations
,
March 2017 in “Journal of The American Academy of Dermatology” This study observed various patterns of permanent alopecia in breast cancer patients treated with taxanes and adjuvant hormonal chemotherapy, hypothesizing disruptions in hair follicle cycles due to chemoinflammatory and hormonal factors.
May 2015 in “Cancer research” This study found that persistent significant alopecia was a common side effect following FEC-docetaxel chemotherapy, with a 33.4% global incidence, highlighting the need for awareness and potential preventative measures like cooling caps during treatment.
24 citations
,
July 1980 in “Journal of Toxicology and Environmental Health” This study found that feeding norethindrone acetate to albino rats over two years caused various dose-related health effects, such as growth retardation and liver changes, but did not increase overall tumor incidence.
7 citations
,
February 2023 in “Plastic & Reconstructive Surgery” This study found that racial minorities face higher costs for unplanned hospital visits after surgery despite controlling for insurance, highlighting health care disparities and suggesting revised payment models as a potential mitigation strategy.
1 citations
,
April 2016 in “Plastic and Reconstructive Surgery – Global Open” This study concluded that oncoplastic breast surgery is a more cost-effective treatment than standard lumpectomy for large-breasted patients, despite higher initial costs.
